Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional
Official Title: An Open-Label, Intrapatient, Dose-Escalation Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of ALXN1210 Administered Intravenously to Patients With Paroxy
Brief Summary: The primary purpose of this study is to evaluate the safety, tolerability and efficacy of multiple IV doses of ALXN1210 administered to patients with PNH